The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
InVitro Fertilization (IVF)-Global Market Insights and Sales Trends 2024
Synopsis
The global InVitro Fertilization (IVF) market size is expected to reach US$ 32530 million by 2029, growing at a CAGR of 7.5% from 2023 to 2029. The market is mainly driven by the significant applications of InVitro Fertilization (IVF) in various end use industries. The expanding demands from the Male Infertility and Female Infertility, are propelling InVitro Fertilization (IVF) market. Intrauterine Insemination (IUI), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Intra Cytoplasmic Sperm Injection (ICSI) segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for InVitro Fertilization (IVF) market, driven by demand from China, the second largest economy with some signs of stabilising, the InVitro Fertilization (IVF) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for InVitro Fertilization (IVF), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global InVitro Fertilization (IVF) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global InVitro Fertilization (IVF) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, InVitro Fertilization (IVF) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of InVitro Fertilization (IVF) covered in this report include Vitrolife AB, Merck Serono, Ferring Pharmaceuticals, Irvine Scientific, GeneaBiomedx, Cooper Surgical, Origio, Genea and Halotech Dna, etc.
The global InVitro Fertilization (IVF) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Vitrolife AB
Merck Serono
Ferring Pharmaceuticals
Irvine Scientific
GeneaBiomedx
Cooper Surgical
Origio
Genea
Halotech Dna
Auxilium Pharmaceuticals
Auxogyn
Ovascience
Andrology Solutions
Global InVitro Fertilization (IVF) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global InVitro Fertilization (IVF) market, Segment by Type:
Intrauterine Insemination (IUI)
Intra Cytoplasmic Sperm Injection (ICSI)
Drug and Hormone Therapies
Others
Global InVitro Fertilization (IVF) market, by Application
Male Infertility
Female Infertility
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of InVitro Fertilization (IVF) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global InVitro Fertilization (IVF) market size is expected to reach US$ 32530 million by 2029, growing at a CAGR of 7.5% from 2023 to 2029. The market is mainly driven by the significant applications of InVitro Fertilization (IVF) in various end use industries. The expanding demands from the Male Infertility and Female Infertility, are propelling InVitro Fertilization (IVF) market. Intrauterine Insemination (IUI), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Intra Cytoplasmic Sperm Injection (ICSI) segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for InVitro Fertilization (IVF) market, driven by demand from China, the second largest economy with some signs of stabilising, the InVitro Fertilization (IVF) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for InVitro Fertilization (IVF), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global InVitro Fertilization (IVF) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global InVitro Fertilization (IVF) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, InVitro Fertilization (IVF) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of InVitro Fertilization (IVF) covered in this report include Vitrolife AB, Merck Serono, Ferring Pharmaceuticals, Irvine Scientific, GeneaBiomedx, Cooper Surgical, Origio, Genea and Halotech Dna, etc.
The global InVitro Fertilization (IVF) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Vitrolife AB
Merck Serono
Ferring Pharmaceuticals
Irvine Scientific
GeneaBiomedx
Cooper Surgical
Origio
Genea
Halotech Dna
Auxilium Pharmaceuticals
Auxogyn
Ovascience
Andrology Solutions
Global InVitro Fertilization (IVF) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global InVitro Fertilization (IVF) market, Segment by Type:
Intrauterine Insemination (IUI)
Intra Cytoplasmic Sperm Injection (ICSI)
Drug and Hormone Therapies
Others
Global InVitro Fertilization (IVF) market, by Application
Male Infertility
Female Infertility
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of InVitro Fertilization (IVF) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of InVitro Fertilization (IVF)
1.1 InVitro Fertilization (IVF) Market Overview
1.1.1 InVitro Fertilization (IVF) Product Scope
1.1.2 InVitro Fertilization (IVF) Market Status and Outlook
1.2 Global InVitro Fertilization (IVF) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global InVitro Fertilization (IVF) Market Size by Region (2018-2029)
1.4 Global InVitro Fertilization (IVF) Historic Market Size by Region (2018-2023)
1.5 Global InVitro Fertilization (IVF) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, InVitro Fertilization (IVF) Market Size (2018-2029)
1.6.1 North America InVitro Fertilization (IVF) Market Size (2018-2029)
1.6.2 Europe InVitro Fertilization (IVF) Market Size (2018-2029)
1.6.3 Asia-Pacific InVitro Fertilization (IVF) Market Size (2018-2029)
1.6.4 Latin America InVitro Fertilization (IVF) Market Size (2018-2029)
1.6.5 Middle East & Africa InVitro Fertilization (IVF) Market Size (2018-2029)
2 InVitro Fertilization (IVF) Market by Type
2.1 Introduction
2.1.1 Intrauterine Insemination (IUI)
2.1.2 Intra Cytoplasmic Sperm Injection (ICSI)
2.1.3 Drug and Hormone Therapies
2.1.4 Others
2.2 Global InVitro Fertilization (IVF) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global InVitro Fertilization (IVF) Historic Market Size by Type (2018-2023)
2.2.2 Global InVitro Fertilization (IVF) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America InVitro Fertilization (IVF) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe InVitro Fertilization (IVF) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific InVitro Fertilization (IVF) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America InVitro Fertilization (IVF) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa InVitro Fertilization (IVF) Revenue Breakdown by Type (2018-2029)
3 InVitro Fertilization (IVF) Market Overview by Application
3.1 Introduction
3.1.1 Male Infertility
3.1.2 Female Infertility
3.2 Global InVitro Fertilization (IVF) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global InVitro Fertilization (IVF) Historic Market Size by Application (2018-2023)
3.2.2 Global InVitro Fertilization (IVF) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America InVitro Fertilization (IVF) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe InVitro Fertilization (IVF) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific InVitro Fertilization (IVF) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America InVitro Fertilization (IVF) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa InVitro Fertilization (IVF) Revenue Breakdown by Application (2018-2029)
4 InVitro Fertilization (IVF) Competition Analysis by Players
4.1 Global InVitro Fertilization (IVF) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in InVitro Fertilization (IVF) as of 2022)
4.3 Date of Key Players Enter into InVitro Fertilization (IVF) Market
4.4 Global Top Players InVitro Fertilization (IVF) Headquarters and Area Served
4.5 Key Players InVitro Fertilization (IVF) Product Solution and Service
4.6 Competitive Status
4.6.1 InVitro Fertilization (IVF) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Vitrolife AB
5.1.1 Vitrolife AB Profile
5.1.2 Vitrolife AB Main Business
5.1.3 Vitrolife AB InVitro Fertilization (IVF) Products, Services and Solutions
5.1.4 Vitrolife AB InVitro Fertilization (IVF) Revenue (US$ Million) & (2018-2023)
5.1.5 Vitrolife AB Recent Developments
5.2 Merck Serono
5.2.1 Merck Serono Profile
5.2.2 Merck Serono Main Business
5.2.3 Merck Serono InVitro Fertilization (IVF) Products, Services and Solutions
5.2.4 Merck Serono InVitro Fertilization (IVF) Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Serono Recent Developments
5.3 Ferring Pharmaceuticals
5.3.1 Ferring Pharmaceuticals Profile
5.3.2 Ferring Pharmaceuticals Main Business
5.3.3 Ferring Pharmaceuticals InVitro Fertilization (IVF) Products, Services and Solutions
5.3.4 Ferring Pharmaceuticals InVitro Fertilization (IVF) Revenue (US$ Million) & (2018-2023)
5.3.5 Irvine Scientific Recent Developments
5.4 Irvine Scientific
5.4.1 Irvine Scientific Profile
5.4.2 Irvine Scientific Main Business
5.4.3 Irvine Scientific InVitro Fertilization (IVF) Products, Services and Solutions
5.4.4 Irvine Scientific InVitro Fertilization (IVF) Revenue (US$ Million) & (2018-2023)
5.4.5 Irvine Scientific Recent Developments
5.5 GeneaBiomedx
5.5.1 GeneaBiomedx Profile
5.5.2 GeneaBiomedx Main Business
5.5.3 GeneaBiomedx InVitro Fertilization (IVF) Products, Services and Solutions
5.5.4 GeneaBiomedx InVitro Fertilization (IVF) Revenue (US$ Million) & (2018-2023)
5.5.5 GeneaBiomedx Recent Developments
5.6 Cooper Surgical
5.6.1 Cooper Surgical Profile
5.6.2 Cooper Surgical Main Business
5.6.3 Cooper Surgical InVitro Fertilization (IVF) Products, Services and Solutions
5.6.4 Cooper Surgical InVitro Fertilization (IVF) Revenue (US$ Million) & (2018-2023)
5.6.5 Cooper Surgical Recent Developments
5.7 Origio
5.7.1 Origio Profile
5.7.2 Origio Main Business
5.7.3 Origio InVitro Fertilization (IVF) Products, Services and Solutions
5.7.4 Origio InVitro Fertilization (IVF) Revenue (US$ Million) & (2018-2023)
5.7.5 Origio Recent Developments
5.8 Genea
5.8.1 Genea Profile
5.8.2 Genea Main Business
5.8.3 Genea InVitro Fertilization (IVF) Products, Services and Solutions
5.8.4 Genea InVitro Fertilization (IVF) Revenue (US$ Million) & (2018-2023)
5.8.5 Genea Recent Developments
5.9 Halotech Dna
5.9.1 Halotech Dna Profile
5.9.2 Halotech Dna Main Business
5.9.3 Halotech Dna InVitro Fertilization (IVF) Products, Services and Solutions
5.9.4 Halotech Dna InVitro Fertilization (IVF) Revenue (US$ Million) & (2018-2023)
5.9.5 Halotech Dna Recent Developments
5.10 Auxilium Pharmaceuticals
5.10.1 Auxilium Pharmaceuticals Profile
5.10.2 Auxilium Pharmaceuticals Main Business
5.10.3 Auxilium Pharmaceuticals InVitro Fertilization (IVF) Products, Services and Solutions
5.10.4 Auxilium Pharmaceuticals InVitro Fertilization (IVF) Revenue (US$ Million) & (2018-2023)
5.10.5 Auxilium Pharmaceuticals Recent Developments
5.11 Auxogyn
5.11.1 Auxogyn Profile
5.11.2 Auxogyn Main Business
5.11.3 Auxogyn InVitro Fertilization (IVF) Products, Services and Solutions
5.11.4 Auxogyn InVitro Fertilization (IVF) Revenue (US$ Million) & (2018-2023)
5.11.5 Auxogyn Recent Developments
5.12 Ovascience
5.12.1 Ovascience Profile
5.12.2 Ovascience Main Business
5.12.3 Ovascience InVitro Fertilization (IVF) Products, Services and Solutions
5.12.4 Ovascience InVitro Fertilization (IVF) Revenue (US$ Million) & (2018-2023)
5.12.5 Ovascience Recent Developments
5.13 Andrology Solutions
5.13.1 Andrology Solutions Profile
5.13.2 Andrology Solutions Main Business
5.13.3 Andrology Solutions InVitro Fertilization (IVF) Products, Services and Solutions
5.13.4 Andrology Solutions InVitro Fertilization (IVF) Revenue (US$ Million) & (2018-2023)
5.13.5 Andrology Solutions Recent Developments
6 North America
6.1 North America InVitro Fertilization (IVF) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe InVitro Fertilization (IVF) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific InVitro Fertilization (IVF) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America InVitro Fertilization (IVF) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa InVitro Fertilization (IVF) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 InVitro Fertilization (IVF) Market Dynamics
11.1 InVitro Fertilization (IVF) Industry Trends
11.2 InVitro Fertilization (IVF) Market Drivers
11.3 InVitro Fertilization (IVF) Market Challenges
11.4 InVitro Fertilization (IVF) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
